Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Ann Surg Oncol
.
2022 Sep;29(9):6049-6083.
doi: 10.1245/s10434-022-11356-z.
Epub 2022 Feb 25.
Authors
Rogini Balachandran
1
2
3
,
Louise Zinck Mogensen
4
,
Peter Christensen
4
5
6
,
Henriette Vind Thaysen
4
5
,
Lene Hjerrild Iversen
4
5
Affiliations
1
Department of Surgery, Aarhus University Hospital, Aarhus, Denmark. rogbal@rm.dk.
2
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. rogbal@rm.dk.
3
Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects after Cancer in the Pelvic Organs, Aarhus, Denmark. rogbal@rm.dk.
4
Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
5
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
6
Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects after Cancer in the Pelvic Organs, Aarhus, Denmark.
PMID:
35217973
DOI:
10.1245/s10434-022-11356-z
No abstract available
Publication types
Review
MeSH terms
Combined Modality Therapy
Cytoreduction Surgical Procedures / adverse effects
Humans
Hyperthermia, Induced* / adverse effects
Hyperthermic Intraperitoneal Chemotherapy
Peritoneal Neoplasms* / surgery